William B. O'Connor

2013

In 2013, William B. O'Connor earned a total compensation of $1.1M as Chief Financial Officer at Medicines, a 18% increase compared to previous year.

Compensation breakdown

Bonus$23,164
Non-Equity Incentive Plan$238,125
Option Awards$146,345
Salary$375,000
Stock Awards$342,989
Other$3,319
Total$1,128,942

O'Connor received $375K in salary, accounting for 33% of the total pay in 2013.

O'Connor also received $23.2K in bonus, $238.1K in non-equity incentive plan, $146.3K in option awards, $343K in stock awards and $3.3K in other compensation.

Rankings

In 2013, William B. O'Connor's compensation ranked 6,080th out of 12,286 executives tracked by ExecPay. In other words, O'Connor earned more than 50.5% of executives.

ClassificationRankingPercentile
All
6,080
out of 12,286
51st
Division
Manufacturing
2,119
out of 4,612
54th
Major group
Chemicals And Allied Products
625
out of 1,462
57th
Industry group
Drugs
449
out of 1,156
61st
Industry
Pharmaceutical Preparations
361
out of 890
59th
Source: SEC filing on April 25, 2016.

O'Connor's colleagues

We found three more compensation records of executives who worked with William B. O'Connor at Medicines in 2013.

2013

Clive Meanwell

Medicines

Chief Executive Officer

2013

Glenn Sblendorio

Medicines

Chief Financial Officer

2013

Paul Antinori

Medicines

General Counsel

You may also like